Form4insider filings, from the source

SEC Form 4 · accession 0000921895-18-000528

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Dec 29, 2017
Accepted (ET)
Feb 12, 2018 · 8:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 9, 2018J10,113—A47,164D
9.00% Series A Cumulative Preferred StockF2,F6,F5Dec 29, 2017J21,410$50.00A405,395IBy: Lone Star Value Investors, LP
Common StockF2,F3holding———83,308IBy: Separately Managed Account
Common StockF2,F4holding———13,910IBy: Lone Star Value Co-Invest I, LP
Common StockF2,F5holding———2,972,592IBy: Lone Star Value Investors, LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses